...
首页> 外文期刊>Macromolecular rapid communications: Publishing the newsletters of the European Polymer Federation >Injectable nanohybrid scaffold for biopharmaceuticals delivery and soft tissue engineering
【24h】

Injectable nanohybrid scaffold for biopharmaceuticals delivery and soft tissue engineering

机译:Injectable nanohybrid scaffold for biopharmaceuticals delivery and soft tissue engineering

获取原文
获取原文并翻译 | 示例
           

摘要

An injectable nanofibrous hydrogel scaffold integrated with growth factors (GFs) loaded polysaccharide nanoparticles was developed that specifically allows for targeted adipose-derived stem cells (ASCs) encapsulation and soft tissue engineering. The nanofibrous hydrogel was produced via biological conjugation of biotin-terminated star-shaped poly(ethylene glycol) (PEG-Biotin) and streptavidin-functionalized hyaluronic acid (HA-Streptavidin). The polysaccharide nanoparticles were noncovalently assembled via electrostatic interactions between low-molecular-weight heparin (LMWH) and N,N,N-trimethylchitosan chloride (TMC). Vascular endothelial growth factor (VEGF) was entrapped in the LMWH/TMC nanoparticles by affinity interactions with LMWH. A nanofibrous hydrogel is produced via the biological conjugation of biotin-terminated star poly(ethylene glycol) and streptavidin-functionalized hyaluronic acid. Vascular endothelial growth factor (VEGF) is entrapped in low-molecular-weight heparin/N,N,N-trimethylchitosan chloride nanoparticles by affinity interactions.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号